|
2002–2005
|
2006–2009
|
2010–2013
| |
2002–2005
|
2006–2009
|
2010–2013
| |
---|
Tertiary Center
|
p value
|
Non-center
|
p value
|
---|
Gender
| | | | | | |
0.106
| | | | | | |
0.081
|
Male
|
1057
|
(73.0%)
|
1070
|
(70.4%)
|
1056
|
(69.6%)
| |
1631
|
(71.2%)
|
1696
|
(71.5%)
|
1652
|
(68.8%)
| |
Female
|
391
|
(27.0%)
|
450
|
(29.6%)
|
461
|
(30.4%)
| |
660
|
(28.8%)
|
677
|
(28.5%)
|
750
|
(31.2%)
| |
Age group
| | | | | | |
0.262
| | | | | | |
0.079
|
18–40
|
862
|
(59.5%)
|
850
|
(55.9%)
|
854
|
(56.3%)
| |
1236
|
(54.0%)
|
1205
|
(50.8%)
|
1203
|
(50.1%)
| |
40–65
|
452
|
(31.2%)
|
517
|
(34.0%)
|
521
|
(34.3%)
| |
797
|
(34.8%)
|
868
|
(36.6%)
|
896
|
(37.3%)
| |
> 65
|
134
|
(9.3%)
|
153
|
(10.1%)
|
142
|
(9.4%)
| |
258
|
(11.3%)
|
300
|
(12.6%)
|
303
|
(12.6%)
| |
Management
| | | | | | |
< 0.001*
| | | | | | |
< 0.001*
|
Non-operative
|
816
|
(56.4%)
|
987
|
(64.9%)
|
1101
|
(72.6%)
| |
994
|
(43.4%)
|
1207
|
(50.9%)
|
1392
|
(58.0%)
| |
Surgical
|
632
|
(43.6%)
|
533
|
(35.1%)
|
416
|
(27.4%)
| |
1297
|
(56.6%)
|
1166
|
(49.1%)
|
1010
|
(42.0%)
| |
Associated injury
| | | | | | | | | | | | | | |
Traumatic brain injury
|
248
|
(17.1%)
|
279
|
(18.4%)
|
248
|
(16.3%)
|
0.337
|
421
|
(18.4%)
|
360
|
(15.2%)
|
388
|
(16.2%)
|
0.011*
|
Cardiopulmonary injury
|
63
|
(4.4%)
|
118
|
(7.8%)
|
165
|
(10.9%)
|
< 0.001*
|
57
|
(2.5%)
|
106
|
(4.5%)
|
130
|
(5.4%)
|
< 0.001*
|
Hemothorax
|
245
|
(16.9%)
|
288
|
(18.9%)
|
305
|
(20.1%)
|
0.08
|
260
|
(11.3%)
|
377
|
(15.9%)
|
433
|
(18.0%)
|
< 0.001*
|
Gastrointestinal injury
|
147
|
(10.2%)
|
122
|
(8.0%)
|
91
|
(6.0%)
|
< 0.001*
|
238
|
(10.4%)
|
183
|
(7.7%)
|
179
|
(7.5%)
|
< 0.001*
|
Kidney injury
|
168
|
(11.6%)
|
192
|
(12.6%)
|
186
|
(12.3%)
|
0.687
|
225
|
(9.8%)
|
222
|
(9.4%)
|
252
|
(10.5%)
|
0.417
|
Liver injury
|
179
|
(12.4%)
|
211
|
(13.9%)
|
170
|
(11.2%)
|
0.082
|
304
|
(13.3%)
|
288
|
(12.1%)
|
268
|
(11.2%)
|
0.086
|
Pelvic fracture
|
70
|
(4.8%)
|
76
|
(5.0%)
|
63
|
(4.2%)
|
0.503
|
71
|
(3.1%)
|
87
|
(3.7%)
|
84
|
(3.5%)
|
0.551
|
Femoral fracture
|
80
|
(5.5%)
|
71
|
(4.7%)
|
68
|
(4.5%)
|
0.376
|
79
|
(3.4%)
|
82
|
(3.5%)
|
103
|
(4.3%)
|
0.214
|
Spinal fracture
|
51
|
(3.5%)
|
65
|
(4.3%)
|
86
|
(5.7%)
|
0.016*
|
46
|
(2.0%)
|
57
|
(2.4%)
|
89
|
(3.7%)
|
0.001*
|
Hospital length of stay days (median [IQR])
|
10
|
[6, 15]
|
9
|
[6, 16]
|
9
|
[6, 15]
|
0.005*
|
9
|
[6, 14]
|
9
|
[6, 14]
|
9
|
[6, 13]
|
0.116
|
ICU length of stay days (median [IQR])
|
2
|
[1, 4]
|
2
|
[1, 4]
|
2
|
[1, 4]
|
0.029*
|
2
|
[0, 4]
|
2
|
[1, 4]
|
2
|
[1, 4]
|
0.001*
|
Ventilator support days(median [IQR])
|
0
|
[0, 2]
|
0
|
[0, 2]
|
0
|
[0, 2]
|
0.002*
|
0
|
[0, 1]
|
0
|
[0, 2]
|
0
|
[0, 2]
|
0.03*
|
In-hospital mortality
|
129
|
(8.9%)
|
143
|
(9.4%)
|
109
|
(7.2%)
|
0.071
|
172
|
(7.5%)
|
208
|
(8.8%)
|
184
|
(7.7%)
|
0.221
|
ISS ≥ 16
|
192
|
(13.3%)
|
398
|
(26.2%)
|
547
|
(36.1%)
|
< 0.001*
|
224
|
(9.8%)
|
328
|
(13.8%)
|
520
|
(21.6%)
|
< 0.001*
|
- COPD chronic obstructive pulmonary disease, IQR interquartile range
- *Statistically significant difference